Doxorubicin is a widely used and promising anticancer drug; however, a severe dose-
dependent cardiotoxicity hampers its therapeutic value. Doxorubicin may cause acute and …

Background As an anthracycline antibiotic, doxorubicin (DOX) is one of the most potent and
widely used chemotherapeutic agents for various types of solid tumors. Unfortunately …

Although doxorubicin (DOX) is among the most widely used anticancer agents, its clinical
application is hampered owing to its cardiotoxicity. Adjuvant therapy with an antioxidant has …

Doxorubicin is an effective chemotherapeutic agent prescribed to treat solid tumors (eg,
ovary, breast, and gastrointestinal cancers). This anti-cancer drug has various side effects …

Doxorubicin (DOX) is an anthracycline antibiotic, which is effectively used in the treatment of
different malignancies, such as leukemias and lymphomas. Its most serious side effect is …

Doxorubicin (DOX) is a potent and widely used anthracycline antibiotic for the treatment of
several malignancies. Unfortunately, the clinical utility of DOX is often restricted due to the …

Doxorubicin is the mainstay of treatment for various haematological malignancies and solid
tumours. However, its clinical application may be hampered by dose‐dependent …

The long-term clinical usefulness of doxorubicin (DOX), an anthracycline with potent
antitumor activity, is limited by DOX-induced cardiotoxicity. Kaempferol, one of the most …

Doxorubicin is a highly effective, first line chemotherapeutic agent used in the management
of hematological and solid tumors. The effective use of doxorubicin in cancer therapy has …

Doxorubicin is useful anticancer drug because it's used in treatment of acute leukemia,
Hodgkin's and non-Hodgkin's lymphomas, and many other malignant neoplasm. The …